Detalhe da pesquisa
1.
Effects of COVID-19 on Pediatric Cancer Care: A Multicenter Study of 11 Middle Eastern Countries.
J Pediatr Hematol Oncol
; 45(1): e87-e91, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36219708
2.
Late effects in high-risk neuroblastoma survivors treated with high-dose chemotherapy and stem cell rescue.
Pediatr Blood Cancer
; 66(1): e27421, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30151986
3.
Can Pediatric Risk of Mortality Score (PRISM III) Be Used Effectively in Initial Evaluation and Follow-up of Critically Ill Cancer Patients Admitted to Pediatric Oncology Intensive Care Unit (POICU)? A Prospective Study, in a Tertiary Cancer Center in Egypt.
J Pediatr Hematol Oncol
; 40(5): 382-386, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29176465
4.
Providing care for pediatric cancer patients in the COVID-19 era: Rapid response recommendations from a developing country.
Pediatr Blood Cancer
; 67(8): e28467, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32539188
5.
Effective and Elaborative Induction Program for Mitigating Myths and Misconceptions Linked to Hematopoietic Stem Cell Transplantation in a Resource Limited Setting.
Indian J Hematol Blood Transfus
; 39(4): 598-609, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37786824
6.
Acute Complications After High-Dose Chemotherapy and Stem-Cell Rescue in Pediatric Patients With High-Risk Neuroblastoma Treated in Countries With Different Resources.
J Glob Oncol
; 4: 1-12, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30241255